Using ‘smart’ technology to improve the outcomes of people with type 2 diabetes and other chronic conditions.

Using ‘smart’ technology to improve the outcomes of people with type 2 diabetes and other chronic conditions.

Using ‘smart’ technology to improve the outcomes of people with type 2 diabetes and other chronic conditions. (#177)

Adrienne O'Neil ¹

The University of Melbourne, Melbourne, VIC, Australia

A major component of effective diabetes self management is initiating and maintaining key health behaviours. Decades of research has clearly demonstrated that sustainable behaviour change - and long term diabetes self management - is best predicted by ongoing monitoring, support and encouragement, as well as assistance in solving problems and addressing any barriers to desirable behavioural patterns. However, the provision of ongoing follow-up and support remains a major challenge, with health systems seldom having the capacity to deliver and support such programs. The rapid uptake of digital technologies provides a unique opportunity to provide wide-reaching and potentially cost effective supports to patients with chronic conditions such as type 2 diabetes. More ‘high tech’ interventions using smartphones and the internet now offer new approaches to monitoring self management and clinical status indicators relevant to diabetes management and progression, linking individuals to tailored care, assisting in problem solving, and, even, providing long term social support and encouragement. This presentation will consider some of our recently conducted complex ‘real world’ intervention trials of telehealth and and smart technology conducted within our Unit over the past 10 years.

Authors contributing to this presentation.

O'Neil, A

Dr Adrienne O'Neil is a Senior Research Fellow, National Health & Medical Research Council ECF and Deputy Head of the NonCommunicable Disease Unit at the Melbourne School of Population & Global Health and University of Melbourne. She is a behavioural scientist with over ten years experience in public health, health services research and epidemiology. She has been developing a research program that focuses on the primary and secondary prevention of cardio-metabolic conditions - specifically for those with mental disorders such as depression. She also specialises in the use of technology for the delivery of effective, contemporary and scalable interventions for real world translation, having spent 6 months researching this area at Stanford University in 2014. Dr O'Neil's research portfolio contains a combination of intervention studies that have conducted in a range of acute, primary care and community-based settings for the prevention and management of type 2 diabetes (e.g. GGT Diabetes Prevention Project), CVD and depression. She has also been involved in several seminal epidemiological studies including the Geelong Osteoporosis Study, AusDiab, MILES-diabetes and the National Survey of Mental Health and Wellbeing. Throughout her career, she has produced 57 publications including 41 scientific papers, 5 published letters, 4 abstracts, 5 book chapters, 1 report and 1 patient manual. This includes first author commentary pieces in the Archives of Internal Medicine, Annals of Internal Medicine and Medical Journal of Australia. In 2011, she wrote a piece for Circulation calling for better recognition and treatment of depression for women after hospitalization for heart attack. To date, she has received ~$2 million of competitive funding.

Using ‘smart’ technology to improve the outcomes of people with type 2 diabetes and other chronic conditions. (#177)

Add notes

O'Neil, A

Login